Status
Conditions
Treatments
About
This research study evaluates an experimental, point-of-care tool that combines Deep Ultraviolet (DUV) light imaging with Artificial Intelligence (AI) to rapidly screen for oral cancer and pre-cancer (dysplasia).
The main goal is to determine if this automated tool can accurately deliver immediate, same-visit triage results (categorizing cells as either non-dysplasia or dysplasia/cancer) without needing chemical stains, sample transport, or off-site laboratory processing.
The following occurs during a singular clinic visit for participants:
This is important given that the five-year survival rates for oral cancer exceed 80% when caught early but drop to under 20% if detected late. By delivering rapid results directly at the clinic, this technology aims to eliminate long waiting periods for lab results, accelerate specialist referrals, and improve access to early screening in community dental and medical clinics.
Full description
This research project establishes a new diagnostic paradigm by transforming oral brush cytology from a centralized, laboratory-dependent procedure into an automated, AI-assisted point-of-care (POC) triage system. Traditional brush cytology relies on chemical staining, physical sample shipping, and off-site expert review, which can introduce diagnostic turnaround delays. By combining label-free optical imaging with automated hardware and deep learning, this system aims to deliver immediate, same-visit triage of suspicious oral lesions directly within primary dental and outpatient clinics.
Optical Physics & Optomechanical Engineering: The core imaging system utilizes Deep Ultraviolet (DUV) microscopy operating in the 200-280 nm spectral range. At these wavelengths, cellular nucleic acids and proteins exhibit strong intrinsic light absorption, enabling submicron-resolution, high-contrast visualization of nuclear architecture without chemical dyes or fluorescent stains.
Transformer-Based AI Framework (CellViT): Cellular analysis and classification are powered by an adapted CellViT deep learning framework, which replaces traditional object-detection architectures like YOLOv7.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
270 participants in 1 patient group
Loading...
Central trial contact
Anh D Le, DDS, PhD; Annachristine Hoover
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal